Ionis Pharmaceuticals

Ionis Pharmaceuticals

World Rank (Jan-05-2024)
2,137
Market Cap (Jan-05-2024)
7.403 Billion USD
World Rank (Jul-30-2023)
2,651
Market Cap (Jul-30-2023)
5.694 Billion USD
World Rank (Jan-07-2022)
3,683
Market Cap (Jan-07-2022)
4.290 Billion USD
World Rank (Jan-01-2021)
2,027
Market Cap (Jan-01-2021)
7.898 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 894
Headquarters Country
USA
Nasdaq / NYSE Code
IONS
Market Cap (Mar-08-2026)
12.23
Employee Count
796
Employee Count as of Date
As on Dec-2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
587 Million USD
Annual Net Income in USD
-269 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
2,533 Million USD
Total Liabilities in USD
1,960 Million USD
Total Equity in USD
572 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Technology
Company Website
IONIS PHARMACEUTICALS INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Biotechnology company with headquarters is in USA.

Annual Results Summary

IONIS PHARMACEUTICALS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022587-410 (Loss)-269 (Loss)
Dec-2021810-14 (Loss)-28 (Loss)
Dec-2020729-172 (Loss)-451 (Loss)
Dec-20191,122365296
Dec-20181,122-61 (Loss)276
Balance Sheet Summary

Total Assets as on Dec-2022 was 2,533 Million USD.

Total Liabilities as on Dec-2022 was 1,960 Million USD.

Total Equity as on Dec-2022 was 572 Million USD

Founded Year
1989
Stock Exchange
Nasdaq
Frankfurt
Company SubCategory
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share